Withings
Connected health company Withings today said the FDA has cleared BeamO, the revolutionary health check-up tool.
This "thermometer of the future" combines the sensors of an electrocardiogram, a stethoscope, and a thermometer to turn the classic thermometer into a tool for the regular monitoring of heart and lung health.
BeamO brings together several functions in a single portable device:
- Two stainless steel electrodes located on its side allow BeamO to perform a medically certified 1-lead electrocardiogram. A grip of BeamO triggers measurements visible in real-time on the animated color LED screen.
- BeamO captures the acoustic sound waves of the chest or back thanks to a piezoelectric disc. Guided by tutorials, users will obtain measurements of the heart and lungs. Equipped with a USB-C to audio jack adapter, the results can be heard via headphones and transferred, stored, and shared with a doctor via the application. During teleconsultations, audio streaming will allow the doctor to guide the placement of the devices and focus on specific areas of interest.
- BeamO makes stable readings of body temperature thanks to a contactless analysis of the temporal artery.
BeamO is available for sale in the US starting on November 13, 2025, and on Amazon and select retail partners across the U.S. in early 2026. BeamO will be sold initially exclusively on withings.com at the price of $249.95, with a 1-month free Withings+ subscription and a Cardio Check-up token.
